Viemed Healthcare Reports Record Revenues in Q3 2025

Viemed Healthcare, Inc. has announced its financial results for the third quarter of 2025, achieving net revenues of $71.9 million, a company record and a 24% increase from the same quarter in 2024. The net income attributable to Viemed reached $3.5 million, or $0.09 per diluted share. Adjusted EBITDA rose to $16.1 million, marking a 15.5% increase compared to the previous year.

During this quarter, Viemed completed a strategic acquisition of Lehan's Medical Equipment, which positively contributed to the company's financial performance. The company also reported a significant rise in patient count for their ventilator and PAP therapy services, evidencing substantial operational growth.

In the context of their 2025 financial guidance, Viemed has slightly adjusted their revenue forecast to between $271 million and $273 million and anticipates an adjusted EBITDA range of $60 million to $62 million. The company emphasizes its solid cash position, allowing for strategic growth opportunities and shareholder returns.